{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:10:12Z","timestamp":1793855412233,"version":"4.6.1"},"reference-count":26,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>(1) Background: Since the advent of zidovudine in 1987, antiretroviral therapy has undergone significant evolution, marked by the introduction of 34 antiretroviral drugs and 24 fixed-dose combinations. Despite these advances, hepatotoxicity remains a formidable challenge, influencing morbidity, mortality, and treatment adherence in HIV-infected patients. This study aims to compare the hepatotoxic effects of latest-generation antiretroviral medications with those of older-generation therapies, assessing their long-term impact on liver health in HIV patients. (2) Methods: This retrospective study analyzed data from 304 HIV patients treated with either latest-generation or older-generation antiretroviral drugs over four years. Patients were monitored for hepatotoxicity through liver function tests at diagnosis, six months, and one-year post-treatment initiation. (3) Results: Initial and six-month liver function tests showed no significant differences between the two groups. However, at one-year post-treatment, patients on latest-generation antiretrovirals exhibited significant improvements in ALT, AST, and ALP levels, suggesting a better safety profile regarding hepatotoxicity. Additionally, a significantly lower incidence of splenomegaly was observed in patients treated with newer medications. (4) Conclusions: The findings suggest that the latest-generation antiretroviral medications may offer a safer profile in terms of hepatotoxicity compared to older therapies, with potential benefits for long-term liver health. This study underscores the importance of continuous monitoring and further research to optimize ART strategies, ensuring improved patient outcomes and quality of life for individuals living with HIV.<\/jats:p>","DOI":"10.3390\/idr16030031","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T12:06:38Z","timestamp":1714651598000},"page":"423-434","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating Hepatotoxicity: A Comparative Analysis of New Generation versus Historical Antiretroviral Agents"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6793-5361","authenticated-orcid":false,"given":"Simona-Alina","family":"Abu-Awwad","sequence":"first","affiliation":[{"name":"Ist Clinic of Obstetrics and Gynecology, \u201cPius Brinzeu\u201d County Clinical Emergency Hospital, 300723 Timisoara, Romania"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-0960","authenticated-orcid":false,"given":"Ahmed","family":"Abu-Awwad","sequence":"additional","affiliation":[{"name":"Department XV\u2014Discipline of Orthopedics-Traumatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Research Center University Professor Doctor Teodor Sora, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8387-7700","authenticated-orcid":false,"given":"Madalina-Ianca","family":"Suba","sequence":"additional","affiliation":[{"name":"Doctoral School, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"},{"name":"Dr. Victor Babes, Infectious Diseases and Pneumophthisiology Hospital Timisoara, 300310 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voichita Elena","family":"Lazureanu","sequence":"additional","affiliation":[{"name":"Department XIII, Discipline of Infectious Diseases, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei-Daniel","family":"Bolovan","sequence":"additional","affiliation":[{"name":"Doctoral School, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"},{"name":"Department XV: Orthopedics-Traumatology, \u201cPius Brinzeu\u201d Emergency Clinical County Hospital, Bld Liviu Rebreanu, No. 156, 300723 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8236-2205","authenticated-orcid":false,"given":"Ovidiu","family":"Rosca","sequence":"additional","affiliation":[{"name":"Department XIII, Discipline of Infectious Diseases, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela-M\u0103d\u0103lina","family":"Turaiche","sequence":"additional","affiliation":[{"name":"Methodological and Infectious Diseases Research Center, Department of Infectious Diseases, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela-Teodora","family":"Benea","sequence":"additional","affiliation":[{"name":"Doctoral School, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"},{"name":"Dr. Victor Babes, Infectious Diseases and Pneumophthisiology Hospital Timisoara, 300310 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4924-7832","authenticated-orcid":false,"given":"Bogdan","family":"Hogea","sequence":"additional","affiliation":[{"name":"Department XV\u2014Discipline of Orthopedics-Traumatology, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"},{"name":"Research Center University Professor Doctor Teodor Sora, \u201cVictor Babes\u201d University of Medicine and Pharmacy, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","article-title":"HIV-1 Antiretroviral Drug Therapy","volume":"2","author":"Arts","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Otto, A.O., Rivera, C.G., Zeuli, J.D., and Temesgen, Z. (2021). Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data. Cells, 10.","DOI":"10.3390\/cells10051263"},{"key":"ref_3","first-page":"36","article-title":"Hepatotoxicity of antiretroviral therapy","volume":"5","author":"Kontorinis","year":"2003","journal-title":"AIDS Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.jhep.2005.11.027","article-title":"Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management","volume":"44","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2147\/HIV.S283076","article-title":"Incidence of Hepatotoxicity and Factors Associated During Highly Active Antiretroviral Therapy in People Living with HIV in Ethiopia: A Prospective Cohort Study","volume":"13","author":"Gebremicael","year":"2021","journal-title":"HIVAIDS Res. Palliat. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3389\/fphar.2017.00831","article-title":"Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment\u2014Clinical Points of View and Practical Considerations","volume":"8","author":"Iacob","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/01913123.2017.1282066","article-title":"Adverse effects of antiretroviral therapy on liver hepatocytes and endothelium in HIV patients: An ultrastructural perspective","volume":"41","author":"Chwiki","year":"2017","journal-title":"Ultrastruct. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/HIV.S120979","article-title":"Assessment of the effect of antiretroviral therapy on renal and liver functions among HIV-infected patients: A retrospective study","volume":"9","author":"Tegene","year":"2016","journal-title":"HIVAIDS Res. Palliat. Care."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Abongwa, L.E., Nyamache, A.K., Charles, F., Torimiro, J., Emmanuel, N., Domkam, I., Eyongetah, M., Jude, B., Mua, F.H., and Bella, S. (2022). Risk factors of severe hepatotoxicity among HIV-1 infected individuals initiated on highly active antiretroviral therapy in the Northwest Region of Cameroon. BMC Gastroenterol., 22.","DOI":"10.1186\/s12876-022-02305-x"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e023140","DOI":"10.1136\/bmjopen-2018-023140","article-title":"Liver damage in patients living with HIV on antiretroviral treatment with normal baseline liver function and without HBV\/HCV infection: An 11-year retrospective cohort study in Guangxi, China","volume":"9","author":"Qin","year":"2019","journal-title":"BMJ Open"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.mbs.2018.05.012","article-title":"Modelling hepatotoxicity and antiretroviral therapeutic effect in HIV\/HBV coinfection","volume":"302","author":"Nampala","year":"2018","journal-title":"Math. Biosci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Benedicto, A.M., Fuster-Mart\u00ednez, I., Tosca, J., Esplugues, J.V., Blas-Garc\u00eda, A., and Apostolova, N. (2021). NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved. Cells, 10.","DOI":"10.3390\/cells10071687"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mohammed, O., Alemayehu, E., Bisetegn, H., Tilahun, M., Gedefie, A., Ebrahim, E., Fiseha, M., Necho, M., and Fiseha, T. (2022). Prevalence of hepatotoxicity among HIV-infected patients in Ethiopia: A systematic review and meta-analysis. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07838-w"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/341084","article-title":"Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination Therapy","volume":"186","author":"Wit","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"818570","DOI":"10.1155\/2015\/818570","article-title":"Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk","volume":"2015","author":"Koenig","year":"2015","journal-title":"Dis. Markers"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.14366\/usg.21152","article-title":"Ultrasonographic evaluation of patients with abnormal liver function tests in the emergency department","volume":"41","author":"Vardar","year":"2022","journal-title":"Ultrasonography"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12671","DOI":"10.1073\/pnas.231140698","article-title":"Mechanism of indinavir-induced hyperbilirubinemia","volume":"98","author":"Zucker","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e25428","DOI":"10.1002\/jia2.25428","article-title":"HIV-associated morbidity and mortality in a setting of high ART coverage: Prospective surveillance results from a district hospital in Botswana","volume":"22","author":"Barak","year":"2019","journal-title":"J. Int. AIDS Soc."},{"key":"ref_19","first-page":"220","article-title":"HAART and Hepatotoxicity","volume":"7","author":"Ezhilarasan","year":"2017","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41572-020-0181-1","article-title":"HIV and antiretroviral therapy-related fat alterations","volume":"6","author":"Koethe","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bia\u0142y, M., Czarnecki, M., and Inglot, M. (2023). Impact of Combination Antiretroviral Treatment on Liver Metabolic Health in HIV-Infected Persons. Viruses, 15.","DOI":"10.3390\/v15122432"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1097\/CM9.0000000000002939","article-title":"Reasons, safety and efficacy analysis for conversion of HAART to TAF\/FTC\/BIC among HIV-infected patients","volume":"136","author":"Xiao","year":"2023","journal-title":"Chin. Med. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e27330","DOI":"10.1097\/MD.0000000000027330","article-title":"Real-world efficacy and safety of switching to bictegravir\/emtricitabine\/tenofovir alafenamide in older people living with HIV","volume":"100","author":"Rolle","year":"2021","journal-title":"Medicine"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Tesfa, E., Siefu, D., Belayneh, Y., and Mekonnen, Z. (2019). Liver enzyme elevation in patients taking HAART compared with treatment na\u00efve controls at Debre Berhan Referral Hospital: A comparative cross-sectional study, Northeast Ethiopia. BMC Res. Notes, 12.","DOI":"10.1186\/s13104-019-4748-4"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/428093","article-title":"Severe Hepatotoxicity Associated with Nevirapine Use in HIV-Infected Subjects","volume":"191","author":"Sanne","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1665-2681(19)32064-2","article-title":"Hepatobiliary diseases in patients with human immunodeficiency virus (HIV) treated with non highly active anti-retroviral therapy: Frequency and clinical manifestations","volume":"4","author":"Poo","year":"2005","journal-title":"Ann. Hepatol."}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/16\/3\/31\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:33:37Z","timestamp":1760106817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/16\/3\/31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["idr16030031"],"URL":"https:\/\/doi.org\/10.3390\/idr16030031","relation":{},"ISSN":["2036-7449"],"issn-type":[{"value":"2036-7449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]}}}